GAMMA Investing
SLDB icon

GAMMA Investing’s Solid Biosciences SLDB Stock Holding History

GAMMA Investing’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$19.8K Buy
2,740
+1,323
+93% +$12K ﹤0.01% 2950
2026
Q2 		$14.2K Buy
1,417
+300
+27% +$2.27K ﹤0.01% 3029
2026
Q1 		$8.04K Buy
1,117
+875
+362% +$5.62K ﹤0.01% 3179
2025
Q4 		$1.36K Buy
242
+146
+152% +$791 ﹤0.01% 3711
2025
Q3 		$592 Buy
+96
New +$561 ﹤0.01% 3693
2025
Q2 		– Sell
-153
Closed -$566 – 3882
2025
Q1 		$566 Buy
153
+39
+34% +$167 ﹤0.01% 3662
2024
Q4 		$456 Buy
114
+91
+396% +$500 ﹤0.01% 3586
2024
Q3 		$160 Buy
+23
New +$187 ﹤0.01% 3531

Other funds holding SLDB

Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
Eastern Bank
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
Versant Capital Management
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

GAMMA Investing's SLDB Position: Q3 2026 in Review

GAMMA Investing increased its Solid Biosciences (SLDB) stake by 93% in Q3 2026, buying an estimated $12K and bringing the position to 2,740 shares worth $19.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2950.

GAMMA Investing first reported a position in SLDB in Q3 2024 and has held it in 8 quarters since. 9 funds tracked by Wall St. Rank hold SLDB as of Q3 2026.

  • GAMMA Investing held 2,740 shares of Solid Biosciences worth $19.8K as of Q3 2026.
  • GAMMA Investing bought 1,323 Solid Biosciences shares in Q3 2026, an estimated $12K.
  • Solid Biosciences made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2950 holding.
  • GAMMA Investing first reported a position in Solid Biosciences in Q3 2024 and has held it in 8 quarters since.
  • 9 funds tracked by Wall St. Rank held Solid Biosciences as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.